Please turn JavaScript on

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

Subscribe in seconds and receive Medical News, Health News Latest, Medical News Today - Medical Dialogues |'s news feed updates in your inbox, on your phone or even read them from your own news page here on follow.it.

You can select the updates using tags or topics and you can add as many websites to your feed as you like.

And the service is entirely free!

Follow Medical News, Health News Latest, Medical News Today - Medical Dialogues |: Medical News, Health News Latest, Medical News Today - Medical Dialogues |

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  140 / week

Message History

December 6, 2025: The U.S. Food and Drug Administration (US FDA) in November 2025 has approved reformulated ranitidine tablets, marking the return of this important H₂ receptor antagonist to the U.S. market after a five-year absence. The approval follows extensive safety testing and manufacturing improvements that ensure product quality thr...


Read full story

A new study published in the journal of Medicine showed that both linagliptin and dapagliflozin have good safety profiles and successfully enhance cardiac function and glycemic management in individuals with type 2 diabetes mellitus (T2DM) and heart failure (HF).

Heart failure is a particularly serious con...


Read full story

Three newly identified compounds were found to strongly inhibit α-glucosidase, an enzyme that plays a central role in breaking down carbohydrates during digestion. Because this enzyme directly affects how quickly sugars enter the bloodstream,...


Read full story

A new study published in the Annals of Medicine and Surgery showed that the severity of acne was not significantly correlated with the use of dairy products or fast food.

Adolescents and young adults frequently suffer from acne vulgaris, a persistent inflammatory skin condition that can seriously lower qua...


Read full story

New Delhi: In a significant ruling with implications for multinational subsidiaries operating in India, the Income Tax Appellate Tribunal (ITAT), Bengaluru Bench, has allowed the appeal filed by Alcon Laboratories (India) Private Limited, setting aside major transfer pricing and expense disallowance additions made by the Income Tax Departme...


Read full story